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Herpes simplex virus (HSV) has a number of genes devoted to immune evasion. One such gene, ICP47, binds to the
transporter associated with antigen presentation (TAP) 1/2 thereby preventing transport of viral peptides into the
endoplasmic reticulum, loading of peptides onto nascent major histocompatibility complex (MHC) class I molecules,
and presentation of peptides to CD8 T cells. However, ICP47 binds poorly to murine TAP1/2 and so inhibits antigen
presentation by MHC class I in mice much less efficiently than in humans, limiting the utility of murine models to
address the importance of MHC class I inhibition in HSV immunopathogenesis. To address this limitation, we generated
recombinant HSVs that efficiently inhibit antigen presentation by murine MHC class I. These recombinant viruses
prevented cytotoxic T lymphocyte killing of infected cells in vitro, replicated to higher titers in the central nervous
system, and induced paralysis more frequently than control HSV. This increase in virulence was due to inhibition of
antigen presentation to CD8 T cells, since these differences were not evident in MHC class I-deficient mice or in mice in
which CD8 T cells were depleted. Inhibition of MHC class I by the recombinant viruses did not impair the induction of
the HSV-specific CD8 T-cell response, indicating that cross-presentation is the principal mechanism by which HSV-
specific CD8 T cells are induced. This inhibition in turn facilitates greater viral entry, replication, and/or survival in the
central nervous system, leading to an increased incidence of paralysis.
Citation: Orr MT, Edelmann KH, Vieira J, Corey L, Raulet DH, et al. (2005) Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. PLoS Pathog
1(1): e7.
Introduction
Herpesviruses are distinguished by their ability to establish
lifelong infection cycling between lytic and latent phases. One
challenge to this lifestyle is that the immune system of the
vertebrate hosts has the opportunity to be repeatedly primed,
thereby increasing the potential for the host to eradicate the
pathogen. To cope with this challenge, herpesviruses have
evolved multiple mechanisms to evade immune detection or
clearance. These mechanisms target all aspects of the immune
response, including antibodies, chemokines, cytokines, natu-
ral killer (NK) cells, and CD4 and CD8 T cells [1,2].
Major histocompatibility complex (MHC) class I molecules
are a particularly attractive target for immune evasion by
viruses, because decreasing expression and/or antigen pre-
sentation by MHC class I can attenuate CD8 T-cell-mediated
recognition of infected cells [3–5]. Inhibition of MHC class I
antigen presentation is a hallmark of the herpesvirus family
with all family members having at least one mechanism to
achieve this. For example, the murine cytomegalovirus
(MCMV) m152 gene product gp40 binds to the MHC class I/
peptide complex in the ER/cis-Golgi compartment preventing
export to the cell surface [6,7]. The human cytomegalovirus
(HCMV) US11 gene product binds nascent MHC class I heavy
chain in the endoplasmic reticulum and targets it to the
cytosol for proteasomal degradation [8,9]. However, any
strategy that lowers surface expression of MHC class I carries
with it the undesirable (from the perspective of the virus)
inverse effect of reducing the inhibitory signal that MHC class
I exerts on NK cell activation. Some herpesviruses compen-
sate for this decrease in MHC class I by expressing proteins
that inhibit cell-surface expression of ligands that activate NK
cells [10]. For example, MCMV m152 inhibits expression of
ligands for the activating NK cell receptor NKG2D, while
MCMV m157 binds to members of the Ly49 family of NK cell
receptors, which include both inhibitory and activating
receptors [11–13].
Herpes simplex virus (HSV) is an a-herpesvirus that
establishes lifelong infection in neuronal cells from which it
periodically reactivates [14]. Like the b-herpesviruses MCMV
and HCMV, HSV inhibits antigen presentation on MHC class
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which to do so: the viral host shutoff protein (vhs) and the
immediate early US12 gene product ICP47. Vhs targets host
mRNA for destruction, thus nonspeciﬁcally shutting down
antigen presentation at several steps [15,16]. ICP47 directly
targets MHC class I antigen presentation by binding to the
transporter associated with antigen presentation (TAP) 1/2
complex, preventing transport of peptides from the cytosol
to the endoplasmic reticulum where peptides are loaded into
the nascent MHC class I heavy-chain b2 microglobulin (b2m)
complex [17–19]. However, genes that would compensate for
the agonistic effect of reduced MHC class I expression on NK
cell activation have not been identiﬁed in HSV.
Although HSV has no known murine homolog, HSV can
infect mice in experimental models. In mice, as in humans,
HSV spreads from peripheral tissues to the dorsal root
ganglia in which it can establish latency or from which it can
spread to the central nervous system (CNS) producing
paralysis and death [20]. Consequently, murine models have
been used extensively to study the pathogenesis and
immunological control of HSV infection. One limitation of
current murine models of HSV infection is that ICP47 poorly
inhibits TAP in mouse cells [21]. This is due to ;100-fold
decreased binding of ICP47 to murine TAP1/2 as compared
to human TAP1/2 [18]. Consistent with this, ICP47 protects
HSV-infected human ﬁbroblasts from destruction by cyto-
toxic T lymphocytes (CTLs), while murine ﬁbroblasts are not
protected [22]. Despite the limited ability of ICP47 to inhibit
murine TAP, a role for ICP47 in evasion of CD8 T-cell-
mediated immunity in mice was suggested by studies in which
CD8 T cells were able to protect mice from a mutant HSV
lacking ICP47 but not from wild-type virus [23]. Given the
difference in the capacity of ICP47 to inhibit peptide loading
by murine versus human TAP, the contribution of CD8 CTL
to HSV immunity in mice may overestimate their role in
control of HSV in humans.
To develop an experimental system in which inhibition
of MHC class I by HSV in mice would more closely parallel
the situation in humans, we generated recombinant herpes
simplex viruses (rHSVs) expressing MCMV m152 or HCMV
US11. Both of these proteins inhibit antigen presentation
by murine MHC class I [24,25]. We report here that these
rHSVs prevented CTL recognition of infected cells in vitro,
resulted in increased viral burden in the CNS, and
increased the frequency of paralysis-induction compared
to mice infected with control HSV. By contrast, these
differences were not observed in MHC class I-deﬁcient
mice or in mice in which CD8 T cells were depleted. The
generation of HSV-speciﬁc CD8 T cells was not affected,
suggesting that the greater pathogenicity of these viruses
resulted from evasion of CD8 T-cell recognition in the
CNS, not impaired priming of the adaptive immune
response.
Results
rHSVs Are Generated
We generated rHSVs expressing HCMV US11 (27US11),
MCMV m152 (27m152), or a mock recombinant expressing
only the gfp/gpt selection cassette (27gfp) as described in
Materials and Methods and shown schematically in Figure 1A.
Proper homologous recombination was conﬁrmed by South-
ern blots for gpt, US11, m152, or the UL26–UL27 junction
region. Insertion of the gfp selection cassette resulted in a 2.4-
kB band shift compared to the parental KOS strain, while
selection cassettes containing US11 or m152 gave band shifts
of 3.8 kB or 4.2 kB, respectively (Figure 1B). These
corresponded with the predicted band sizes indicating
correct targeting (Figure 1B). The revertant virus generated
from 27gfp (27gfpR) appeared identical to KOS. All viral
genomic DNA hybridized with the HSV 26–27 probe as
shown. Conversely, only 27gfp, 27US11, and 27m152 hybri-
dized with a gpt probe, and only 27m152 and 27US11
hybridized with an m152 and US11 probe, respectively (data
not shown). Thus all recombinant viruses contain the
appropriate genes inserted into the UL26–UL27 junction
region.
27US11 and27m152 SpecificallyInhibitMurine MHC Class I
To determine whether 27m152 and 27US11 inhibit surface
expression of murine MHC class I more efﬁciently than the
control 27gfp, we analyzed expression on infected murine
ﬁbroblasts by ﬂow cytometry. The control 27gfp demonstra-
ted a modest reduction in surface expression of MHC class I
18 h after infection (Figure 2A and 2B), which was similar to
the parental KOS strain (data not shown) and consistent with
nonspeciﬁc vhs-mediated inhibition. Both 27US11 and
27m152 inhibited MHC class I surface expression to a greater
extent than the 27gfp control. While 27m152 inhibited all
tested murine MHC class I alleles, 27US11 inhibited D
d,K
b,
and D
b but not K
d, which is consistent with results reported
by others [24].
Owing to the slow turnover of MHC class I on the cell
surface, total MHC class I expression will underestimate the
impact of US11 and m152 on presentation of viral peptides
on newly synthesized MHC class I to CD8 T cells. To test
directly the effects of rHSVs on recognition of infected
targets, we examined the lysis of infected ﬁbroblasts by CTL
in vitro. HSV-speciﬁc CTL, which efﬁciently lysed 27gfp-
infected ﬁbroblasts, lysed ﬁbroblasts infected with 27US11 or
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Synopsis
While animal models are often instructive in understanding human
diseases, many factors that influence disease differ between mouse
and man. Although mice can be experimentally infected with HSV-1,
this virus has evolved as a human pathogen. One facet of this
evolution is HSV’s mechanisms to evade the immune response,
allowing the virus to persist for the lifetime of the human host. This
evasion includes preventing CD8 T cells from recognizing and killing
infected cells by inhibiting the expression of the molecule that
presents viral peptides to CD8 T cells: major histocompatibility
complex (MHC) class I. HSV is unable to inhibit mouse MHC class I,
thus rendering this immune-evasion strategy inoperative in the
mouse. To better understand the biology of HSV infection and the
immune response to this virus in humans, the authors corrected this
deficiency by inserting a gene which inhibits murine MHC class I.
This recombinant virus demonstrates that MHC class I inhibition is
an important determinant of disease progression. The authors found
that the recombinant HSV still effectively elicits a CD8 T-cell
response, but this response is ineffective in controlling the infection.
This finding reveals the important distinction between the size of
the immune response and the effectiveness of the response, which
may be important to HSV vaccine studies.27m152 less effectively (Figure 2C and 2D). Although, as
determined by ﬂow cytometry, overall inhibition of cell-
surface MHC class I was greater in the H-2
b (Figure 2B) than
in the H-2
d cells (Figure 2A), the decrease in lysis efﬁciency of
cells infected with 27US11 and 27m152 compared to 27gfp
(and KOS, data not shown) was observed both with infected
H-2
d (Figure 2C) and H-2
b (Figure 2D) targets. These data
demonstrate that 27US11 and 27m152 have a gain-of-
function resulting in increased inhibition of MHC class I
antigen presentation and inhibition of CTL-mediated lysis of
infected murine cells.
27m152, but Not 27US11, Inhibits NKG2D Ligands,
Preventing NK-Cell-Mediated Lysis
Because MHC class I molecules are ligands for inhibitory
receptors on NK cells, inhibition of MHC class I surface
expression would be predicted to render cells infected with
27US11 and 27m152 more vulnerable to NK-cell-mediated
clearance [26]. However, MCMV m152 also inhibits expres-
sion of the Rae-1 family of ligands for the NKG2D-activating
receptor on NK cells; thus 27m152 should also antagonize NK
cell recognition [12,13]. By contrast, HCMV US11 is not
known to inhibit the expression of NKG2D ligands, and
therefore cells infected with 27US11 should be more
vulnerable to lysis by NK cells. Consistent with these
predictions, 27m152, but not 27US11, inhibited the expres-
sion of NKG2D ligands on infected ﬁbroblasts (Figure 3A),
and 27US11-infected ﬁbroblasts were more readily lysed by
NK cells than 27gfp-infected ﬁbroblasts. Conversely, lysis of
27m152-infected cells was similar to lysis of cells infected with
the control 27gfp virus (Figure 3B). Since the only reported
function of HSV ICP47 is to block MHC class I antigen
presentation, 27US11 appears to more closely parallel in mice
the immune-evasion proﬁle of HSV in humans.
Recombinant Viruses Grow as Well as Wild-Type in Vitro
All three gene products ﬂanking the insertion area (UL26,
UL26.5, and UL27) are required for in vitro growth [27]. To
conﬁrm that recombination did not alter neighboring gene
products, we analyzed the single-step growth kinetics of each
virus. Growth curves over a 24-h period revealed that each
recombinant virus grew at the same rate as the parent virus
(Figure 4A and 4B). Thus, growth of recombinant viruses is
not impaired, demonstrating that no genes essential to in
vitro growth, including UL26, UL26.5, and UL27, were
altered. This ﬁnding was conﬁrmed by quantitative RT-PCR
for UL26, UL26.5, and UL27 mRNA. Expression for each gene
was similar for all three recombinant viruses and for KOS
virus (data not shown); expression of GFP and GPT was also
similar for all three recombinant viruses.
The gfp-Containing Selection Cassette Attenuates
Recombinant Viruses in Vivo
Recently, Halford et al. reported a KOS-strain rHSV
expressing gfp driven by the HCMV immediate early
promoter inserted between UL26 and UL27 [28]. This virus
demonstrated a 50% increase in time-to-death after ocular
infection of scid mice of C57Bl/6 or BALB/c background. To
determine whether the gfp/gpt selection cassette used to
generate 27gfp, 27US11, and 27m152 resulted in a similar
attenuation in vivo, we compared the neuroinvasiveness and
neurovirulence of 27gfp to the parental KOS strain and the
revertant 27gfpR. Six days post-infection, viral titers from the
footpad, dorsal root ganglia, and spinal cord were similar
between BALB/c mice infected with KOS or 27gfpR. Although
the viral burden in the footpads of 27gfp-infected mice was
similar to KOS- or 27gfpR-infected mice, there was a ;10-
fold reduction of virus in the dorsal root ganglia and ;100-
fold reduction of virus in the spinal cord (Figure 5A). Thus,
Figure 1. Generation of rHSVs
(A) rHSVs expressing MCMV m152 (27m152), HCMV US11 (27US11), or only the selection cassette (27gfp) were generated via homologous
recombination with KOS strain HSV-1. Contents and location of insertions are indicated. Arrows indicate direction of transcription. The probe used to
isolate correctly recombined viruses is indicated.
(B) Genomic DNA from KOS, 27US11, 27m152, 27gfp, and 27gfpR was digested with the indicated restriction enzymes and probed for the junction of
HSV UL26–UL27. The predicted band sizes are indicated in the tabular inset.
DOI: 10.1371/journal.ppat.0010007.g001
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while removal of the cassette restored it. This decrease in
neuroinvasiveness correlated with decreased neurovirulence,
as 80% of mice infected with KOS or 27gfpR succumbed to
paralysis by day 10, while all mice infected with 27gfp
retained full mobility (Figure 5B). As the revertant is identical
to the parental virus in both neuroinvasiveness and neuro-
virulence, and 27US11 and 27m152 contain this selection
cassette, we used 27gfp as a control to determine the effects
of MHC class I inhibition by 27US11 or 27m152 in vivo.
Inhibition of MHC Class I Is a Virulence Factor
There was no difference in the viral burden in the dorsal
root ganglia or hind footpad of BALB/c mice inoculated with
27gfp, 27US11, or 27m152. However ;100-fold more virus
was recovered from the spinal cord of mice infected with
27US11 or 27m152 compared to 27gfp (Figure 6A). Consis-
tent with this increase in neuroinvasiveness, 27US11 and
27m152 induced paralysis in 70% of mice, while 27gfp did not
induce paralysis with this inoculum (Figure 6B). Similar
results were obtained in BALB.B mice (data not shown).
Increased Neurovirulence Is Due to Inhibition of MHC
Class I Antigen Presentation to CD8 T Cells
If these differences in neuroinvasiveness and neuroviru-
lence are solely due to altered antigen presentation to CD8 T
cells by MHC class I on infected cells, then 27gfp should be as
neurovirulent as 27m152 or 27US11 in mice lacking MHC
class I expression and in mice depleted of CD8 T cells.
Consistent with this prediction and in sharp contrast to
ﬁndings in wild-type mice (Figure 6), titers of 27gfp in the
footpad, dorsal root ganglia, and spinal cord of b2m
 / mice at
day 6 were equivalent to those for 27US11 (Figure 7A), and
the frequency of paralysis in MHC class I-deﬁcient b2m
 / 
Figure 2. 27US11 and 27m152 Inhibit Murine MHC Class I Preventing Lysis by HSV-Specific CTL
(A) K-BALB (H-2
d) and (B) MC57G (H-2
b) fibroblast cell lines were uninfected (solid line) or infected (dashed line) at an MOI of 5:1 with 27gfp, 27US11, or
27m152 for 18 h and analyzed for surface MHC class I expression. Filled histograms are isotype controls. The percentage reduction in mean fluorescent
intensity from uninfected to infected cells is indicated.
(C) and (D) Cells were infected as for (A) and (B) and co-incubated with CTL isolated from HSV-infected (C) BALB/c or (D) BALB.B mice at the indicated
effector-to-target ratio.
DOI: 10.1371/journal.ppat.0010007.g002
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(Figure 7B). Moreover, the titers of 27gfp in the footpad,
dorsal root ganglia, and spinal cord of wild-type mice
depleted of CD8 T cells were equivalent to those for
27US11 and 27m152 on day 6 (Figure 7C). Similar ﬁndings
were obtained at earlier time points—viral burdens in the
spinal cord on day 4 were already signiﬁcantly higher in mice
infected with 27US11 compared to mice infected with 27gfp,
and this difference was also abolished by CD8 depletion (data
not shown). Conversely, depletion of CD4 T cells did not
abolish the increase in viral load in the spinal cord of
27US11- or 27m152-infected BALB/c, as compared to 27gfp-
infected mice (Figure S1). These ﬁndings indicate that HSV-
speciﬁc CD8 T cells are controlling 27gfp, but not 27US11 or
27m152, and are consistent with the notion that the increased
neurovirulence and neuroinvasiveness of 27US11 and
27m152 rHSV are attributable to MHC class I inhibition
and evasion of CD8 T cells.
MHC Class I Inhibition Does Not Affect the Numbers of
HSV-Specific CD8 T Cells
The increased neurovirulence of 27US11 and 27m152
could result from impaired generation of HSV-speciﬁc CD8
T cells, impaired recognition of infected cells in neural
tissues, or both. Recent work suggests that the generation of
HSV-speciﬁc CD8 T cells in mice infected with wild-type HSV
relies on cross-presentation of viral antigens by dendritic
cells [29]. If this is the case, increased MHC class I inhibition
by 27US11 and 27m152 should not affect the induction of
HSV-speciﬁc CD8 T cells.
To address this, we infected BALB.B mice, which are
congenic with BALB/c mice, and similar in their susceptibility
to HSV, but of the H-2
b haplotype. Since ;90% of HSV-
speciﬁc CD8 T cells in H-2
b mice recognize the peptide gB498–
505 presented by H-2K
b, BALB.B mice allow accurate
enumeration of antigen-speciﬁc CD8 T cells [30]. At the peak
of infection, 27US11, 27m152, and 27gfp induced similar
numbers of gB-speciﬁc IFN-c-producing CD8 T cells (Figure
8). Thus, the difference in neuroinvasiveness and neuro-
virulence between these viruses was not due to altered
generation of gB-speciﬁc CD8 T cells.
Figure 3. 27m152, but Not 27US11, Evades NK Recognition by Inhibiting
NKG2D Ligands
(A) BALB/c fibroblasts were uninfected (solid line) or infected (dashed
line) for 18 h at an MOI of 5:1 with 27gfp, 27US11, or 27m152 (dashed
line) and stained with NKG2D tetramer. Solid histogram is uninfected
cells stained with an irrelevant tetramer. The percentage reduction in
mean fluorescent intensity from uninfected to infected cells is indicated.
(B) Cells were prepared as in (A) and co-incubated with splenocytes from
naı ¨ve RAG1
 /  BALB/c mice treated with polyI:C 24 h earlier at the
indicated effector-to-target ratio.
DOI: 10.1371/journal.ppat.0010007.g003
Figure 4. Single-Step Growth Kinetics of rHSVs Are Similar to KOS
Vero cells were infected at an MOI of 5:1 with KOS plus (A) 27m152 or
27US11, or (B) 27gfp. Cells and supernatants were harvested at indicated
times and viral titers were determined on vero cells.
DOI: 10.1371/journal.ppat.0010007.g004
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In this report, we show that two different rHSVs, 27US11
and 27m152, efﬁciently inhibited antigen presentation by
MHC class I molecules on murine cells, as does wild-type HSV
on human cells. BALB/c and BALB.B mice infected with
either of these two rHSVs showed an increased incidence of
paralysis induction in vivo compared to mice infected with
the control 27gfp virus. Paralysis induction correlated with
higher viral burden in the CNS, but not in the footpad or the
peripheral nervous system. This increase in neurovirulence
occurred despite the presence of a strong antigen-speciﬁc
CD8 T-cell response, the size of which was not diminished in
mice infected with 27US11 or 27m152 compared to 27gfp. By
contrast, increased neurovirulence of 27US11 and 27m152
did correlate with the reduced sensitivity of target cells
infected with these viruses to CD8 CTL lysis in vitro. The
greater neurovirulence of 27US11 and 27m152 was not
observed in MHC class I-deﬁcient mice or in wild-type mice
depleted of CD8 T cells. Taken together, these data indicate
that inhibition of MHC class I antigen presentation by HSV is
a neurovirulence factor, and that the primary mechanism for
this increased virulence was the inhibition of target-cell
recognition by antigen-speciﬁc CD8 T cells.
A previous study addressed the importance of ICP47-
mediated inhibition of MHC class I antigen presentation by
HSV in mice [23]. When HSV-susceptible A/J or BALB/c mice
were challenged by ocular inoculation with a mutant HSV
lacking ICP47, this strain induced a lower incidence of
neurologic symptoms and death than the parental strain F.
This difference was ablated when mice were depleted of CD8
cells and in mice that lacked CD8 T cells. This study suggested
that although ICP47 has a much reduced impact on TAP-
dependent antigenic peptide transport in murine cells versus
Figure 5. The Selection Cassette Attenuates Neuroinvasiveness and
Neurovirulence
BALB/c mice were infected in the hind footpads with 2.5 3 10
5 pfu of
KOS, 27gfp, or 27gfpR.
(A) The indicated tissues were isolated on day 6, homogenized, and viral
titers were determined on vero cells.
(B) Ten (27gfp) or 20 (KOS and 27gfpR) mice per virus were monitored for
paralysis induction for 14 d. Mice displaying ataxia or paralysis were
euthanized.
DOI: 10.1371/journal.ppat.0010007.g005
Figure 6. Inhibition of MHC Class I Increases Neuroinvasiveness and
Neurovirulence
BALB/c were infected in the hind footpads with 2.5 3 10
5 pfu of 27gfp,
27US11, or 27m152.
(A) The indicated tissues were isolated on day 6, homogenized, and viral
titers were determined on vero cells.
(B) Ten mice per virus were monitored for paralysis induction for 14 d.
Mice displaying ataxia or paralysis were euthanized.
DOI: 10.1371/journal.ppat.0010007.g006
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in mice in vivo. However, the relatively weak effect of ICP47
in murine cells may underestimate its importance in viral
pathogenesis in humans [21,22]. Using rHSVs that more
closely approximate in mice the magnitude of MHC class I
inhibition by wild-type HSV in humans, the impact of MHC
class I inhibition on neurological outcome was clear—the
titers of 27US11 and 27m152 were more than 100-fold higher,
and the frequency of paralysis was signiﬁcantly greater than
27gfp.
In the previous study, no attempt was made to determine
whether the difference in neurological outcome was associ-
ated with differences in viral titers in peripheral tissues or the
CNS or with differences in the generation of antigen-speciﬁc
CD8 T cells [23]. We found that, despite robust inhibition of
antigen presentation by murine MHC class I, the only
signiﬁcant difference in viral titers was found in the CNS,
suggesting a focused role for this evasion strategy. This
focused immune evasion may result from the greater impact
of inhibition of MHC class I antigen presentation on cells that
express low levels of MHC class I, such as neurons during
acute infection, making the infected CNS more susceptible to
this immune-evasion strategy [31].
Inhibition of antigen presentation on MHC class I may
impact CD8 T-cell response to HSV infection at either or
both of two distinct phases. First, inhibition could limit the
size of the antigen-speciﬁc CD8 T-cell response. However, we
found that the frequency of HSV-speciﬁc CD8 T cells was not
diminished in response to infection with rHSVs that
effectively inhibited MHC class I antigen presentation. Our
ﬁndings provide strong support for the notion that CD8 T-
cell priming in mice infected with HSV is carried out by
cross-priming, as proposed by others from studies with wild-
type HSV [29,32,33]. The second phase at which inhibition
may impact outcome is at the site of productive infection, in
the peripheral tissues, peripheral nervous system, or CNS.
The selective increase in viral titers in the CNS in mice
infected with 27US11 and 27m152 in the absence of differ-
ences in the magnitude of the CD8 T-cell response is
compatible with the notion that the primary effect of MHC
class I inhibition by HSV is to prevent recognition of infected
cells by virus-speciﬁc CD8 T cells in the CNS. Thus,
generation of an immune response does not always predict
the functional relevance of that response. This distinction is
important to the evaluation of vaccines targeted at pathogens
Figure 7. Differences in Neuroinvasiveness and Neurovirulence Are
Dependent on MHC Class I and CD8 T Cells
b2m
 /  BALB/c mice were infected in the hind footpads with 3.0 3 10
4
pfu of 27gfp, 27US11, or 27m152. Note that a lower inoculum was used
in these experiments with b2m
 /  mice than in wild-type BALB/c mice
shown in other figures.
(A) The indicated tissues were isolated on day 6, homogenized, and viral
titers were determined on vero cells.
(B) Nine mice per virus were monitored for paralysis induction for 14 d.
Mice displaying ataxia or paralysis were euthanized.
(C) BALB/c mice were depleted of CD8 cells and infected with 2.5 3 10
5
pfu of the indicated virus in the hind footpads. Viral titers were
determined on day 6.
DOI: 10.1371/journal.ppat.0010007.g007
Figure 8. The Size of the CD8 T-Cell Response to rHSVs Is Not Altered by
MHC Class I Inhibition
Lymphocytes from the draining popliteal lymph nodes were isolated
from BALB.B mice on day 6 of infection with 27gfp, 27US11, or 27m152.
Lymphocytes were stimulated with HSV gB498–505 for 5 h then stained for
CD8 and intracellular IFN-c. Of the unstimulated CD8
þ cells, ,0.1% were
IFN-c
þ.
DOI: 10.1371/journal.ppat.0010007.g008
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poxviruses.
Although depletion of CD8 T cells had a profound impact
on the amount of 27gfp in the spinal cord, there was little
difference in titers of any of the rHSVs in the footpad and
dorsal root ganglia between intact and depleted mice (see
Figures 6A and 7C). This result suggests that the primary
impact of CD8 T-cell immunity to HSV is in the CNS. That
depletion of CD8 T cells in mice infected with 27US11 or
27m152 did not affect CNS viral titers indicates that the
effect of MHC class I inhibition is also manifest primarily at
this site.
The effect of m152 expression in HSV on viral titer is
different from the effect of m152 in MCMV. As reported by
others, deletion of m152, together with the other MHC class I
inhibitors expressed by MCMV, m04 and m06, has no effect
on viral titers in the lung [34]. This difference may be due to
the different tropisms of HSV and MCMV. Whereas MCMV
infects cells with moderate-to-high expression of MHC class I,
HSV targets neuronal cells which express very little MHC
class I [31], and the impact of MHC class I inhibition would be
more apparent in cells that normally express low levels of
MHC class I. This difference may explain the signiﬁcant
increase in viral titer in the CNS of 27m152- and 27US11-
infected mice, while lung titers of wild-type and
D04þD06þD152 MCMV are similar.
While the outcome of infection with 27US11 and 27m152
viruses in vivo was similar, and these viruses inhibited CD8 T-
cell-mediated killing of infected cells in vitro to a similar
degree, cells infected with 27US11 but not 27m152 were more
susceptible to killing by NK cells in vitro. Together, these
ﬁndings suggest that evasion of NK cells does not substan-
tially impact the outcome of acute HSV infection when CD8
T-cell recognition is impaired in mice of the susceptible
BALB background. Furthermore, depletion of NK cells with
anti-asialoGM1 antiserum did not abrogate the difference in
viral titers in the CNS in mice infected with 27US11 and
27m152 compared to 27gfp—on day 3, titers of 27US11 and
27m152 were similar, and both were signiﬁcantly greater than
the titer of 27gfp (data not shown). It is possible that this
ﬁnding may be mouse-strain-speciﬁc, as is the case for m152-
mediated NK cell evasion for MCMV [13].
Another limitation of traditional murine models of HSV
infection is the lack of spontaneous reactivation in vivo,
which is a hallmark of human infection. This may reﬂect the
fact that latently infected mice maintain HSV-speciﬁc CD8 T
cells in the infected ganglia, which can prevent reactivation of
wild-type HSV in vitro [35]. Given the greater efﬁciency with
which they evade CD8 recognition, it is possible that 27US11
and 27m152 may display altered latency features in mice
compared to wild-type HSV.
Materials and Methods
Cell lines and mice. Vero cells were used for isolation of
recombinant viruses. Viral stocks were prepared from infected vero
cells at 90%–100% cytopathic effect. Stocks were sonicated, stored at
 80 8C, and titered on vero cells. Plaque formation was visualized with
crystal violet stain in 10% formaldehyde. Revertant virus was isolated
from STO cells (ATCC, Manassas, Virginia, United States) that lack
HPRT making them resistant to 6-thioguanine toxicity. Murine
ﬁbroblast cell lines (ATCC) MC57G from C57Bl/6 and K-BALB from
BALB/c mice were used to assess MHC class I expression and CD8 T-
cell- and NK-cell-mediated lysis.
Female BALB/c and Rag1
 /  (BALB/c background) were purchased
from Jackson Laboratory (Bar Harbor, Maine, United States) and
used at 6–8 wk of age. BALB.B and b2m
 /  (BALB/c background)
breeder pairs were purchased from Jackson Laboratory and bred in-
house. All mice were maintained in the University of Washington SPF
facility. All studies were approved by the University of Washington
Animal Care and Use Committee.
Generation of rHSV. To determine the effect of MHC class I
inhibition on HSV infection in mice, we generated rHSVs that
express MCMV m152 or HCMV US11, denoted 27m152 and 27US11,
respectively (see Figure 1). Additionally, a control virus termed 27gfp,
which expresses the selection cassette used to isolate 27m152 and
27US11, was generated. A 2.5-kB EcoR I–Hind III fragment in the
UL26–UL27 region of the HSV genome was isolated and cloned into
pUC19. A unique Not I site in the non-coding region that separates
the UL26 and UL27 open reading frames was mutated to a Spe I site
and used for generation of the targeting vector. A selection cassette
containing eGfp driven by the EF-1 promoter and E. coli guanosyl-
phosoribosyltransferase (gpt) driven by the PGK-1 promoter was
cloned into the Spe I site. The original Not I site is located in the
polyA signal of UL26. To correct for this, the bi-directional SV40
polyA was also included. This targeting vector was used to generate
27gfp via homologous recombination.
The targeting vector was digested with EcoR I and Hind III, and 10
lg of DNA was electroporated into vero cells using a Bio-Rad
(Hercules, California, United States) GenePulser Xcell (273 V, 1,100
lF, 186 X, and 0.4-mm cuvette). Electroporated cells were plated
insixwellplatesandinfectedwith2.5310
5 pfuKOSstrainHSV-124h
after electroporation.
Similarly, 27US11 and 27m152 were generated by inserting HCMV
US11 or MCMV m152 into the gfp/gpt-targeting vector under the
control of the HCMV IE promoter. MCMV m152 was PCR-ampliﬁed
from viral genomic DNA, while HCMV US11 was isolated from an
expression vector (provided by Stan Riddell, Fred Hutchinson Cancer
Research Center). Recombinant viruses were plaque-puriﬁed based
on gfp expression, passed once through BALB/c mice, and re-isolated
from the spinal cord to ensure neuroinvasiveness. A revertant virus
for 27gfp, termed 27gfpR, was generated via homologous recombi-
nant in STO cells and isolated by loss of gfp expression. Isolation of
the revertant virus was supported by negative selection in the
presence of 40 lg/ml 6-thioguanine, which is converted to the toxic 6-
thioxanthine by GPT [36].
MHC class I and NKG2D surface expression. MC57G (H-2
b)o rK -
BALB (H-2
d) ﬁbroblast cell lines were infected at a multiplicity of
infection (MOI) of 5:1 for 18 h in the presence of 200 lM gancyclovir.
Cells were resuspended in 100 ll of phosphate-buffered saline þ 1%
bovine albumin and 0.09% sodium azide with a-CD16/32 (1:100) as an
Fc-blocking reagent and phycoerythrin-conjugated a-H-2K
b (1:100),
a-H-2D
b (1:25), a-H-2K
d (1:100), a-H-2D
d (1:100), muIgG2aj and
muIgG2bj isotype controls, NKG2D tetramer (1:1000), or irrelevant
tetramer (1:1,000) for 30 min on ice. Phycoerythrin-conjugated
tetramers were produced as previously described [37]. Analysis was
performed with a Becton Dickenson (Palo Alto, California, United
States) FACSscan. Antibodies were purchased from BD Biosciences
Pharmingen (San Diego, California, United States).
CTL and NK lysis. MC57G or K-BALB cells were infected at an
MOI of 5:1 for 11 h (for CTL assays) or for 8 h (for NK cell assays) in
the presence of 200 lM gancyclovir. Cells were resuspended in 300 ll
of warm media with 30 ll of fresh
51Cr (PerkinElmer, las.perkinel-
mer.com). Cells were incubated at 37 8C for two 1-h periods and
washed twice with warm media. Co-incubation of 10
5 cells/well took
place for 5 h (CTL) or 8 h (NK) with effector cells. Eighteen hours
after infection, 100 ll of media was collected and analyzed on a
Wallac 1470 Wizard gamma counter (PerkinElmer). CD8 CTLs were
derived from the draining lymph node of day-6 HSV-infected
BALB.B or BALB/c mice. For 6 d, 10
6 lymphocytes were cultured in
DMEM (Gibco, San Diego, California, United States) plus 10% FBS
with 1:100 anti-CD3 and 25 lg/ml recombinant huIL-2. Media was
changed on days 3 and 5 with fresh huIL-2. These CTL were added to
target cells in graded numbers. Activated NK cells were derived from
splenocytes from Rag1
 /  BALB/c mice injected i.p. with 200 lg
polyI:C 24 h prior to sacriﬁce. Total splenocytes were added to target
cells in graded numbers. Speciﬁc lysis was determined: percentage
speciﬁc lysis¼(count minimum)/(total lysis minimum lysis)3100.
Single-step growth in vitro. Vero cells were infected at an MOI of
5:1 for 1 h at 4 8C to allow viral attachment. Cells were then washed
thrice with cold PBS and warm RPMI media with 10% FBS added (t¼
0). Cells were incubated at 37 8C for 1 h. Media was then removed and
cells were quickly washed twice with sodium citrate buffer (pH 3.0)
and rinsed thrice with warm PBS. Warm media was then replaced and
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three wells per virus was collected; cells were then trypsinized and
mixed with the corresponding media. Samples were stored at  80 8C
and titered on vero cells.
Infection of mice. Mice were infected in the hind footpads with the
indicated inocula following dermal abrasion, as described previously
[38]. In this model, virus travels anterograde up the enervating sciatic
nerve to the dorsal root ganglia, replicates in the ganglion, and can
then return to the site of infection via retrograde axonal transport
resulting in a primary lesion of the footpad. Virus in the dorsal root
ganglia can also bridge the synapse and enter the CNS at the spinal
cord, from which it may ascend towards the brain. Infected mice were
monitored twice daily for 14 d for ataxia and hind-limb paralysis.
Previous ﬁndings indicated that more than 80% of mice displaying
paralysis succumb to infection; thus paralyzed mice were euthanized
in accordance with our IACUC protocol.
In vivo viral titers. Infected mice were euthanized on day 6 of
infection. Hind footpads, dorsal root ganglia with proximal sciatic
nerve, and spinal cord were isolated and snap frozen on dry ice.
Samples were stored at  80 8C. All samples were homogenized and
titered in triplicate on vero cells.
Antibody depletion. Mice were depleted of CD4 or CD8 T cells by
i.p. injection of 200 ll of 1 mg/ml anti-CD4 (GK1.5) or anti-CD8
(clone 2.43) on two consecutive days, and were infected 2 d later. Mice
were depleted of NK cells by i.p. injection of 100 llo fa-asialo-GM1
(Wako Biochemical, http://www.wako-chemicals.de) 1 d before in-
fection.
Quantiﬁcation of CD8 T-cell response. BALB.B mice were infected
with 2.5 3 10
5 pfu of HSV and sacriﬁced on day 6. Single-cell
suspensions were prepared from their draining popliteal lymph
nodes. For IFN-c production, cells were stimulated with 5 lM of the
immunodominant HSV peptide glycoprotein B498–505 (gB498–505)
(United Biochemical Research, Seattle, Washington, United States)
for 5 h in the presence of BD GolgiStop, followed by surface staining
with anti-CD8-FITC (1:100), permeabilized as above and stained for
intracellular IFN-c with anti-IFN-c-PE (1:200). Unstimulated lym-
phocytes were used as a negative control. Speciﬁc IFN-c production¼
percentage CD8
þ IFN-c
þ stimulated   unstimulated. All antibodies
were purchased from BD Biosciences Pharmingen.
Supporting Information
Figure S1. Depletion of CD4 T Cells Does Not Equalize Spinal Cord
Titers of 27 gfp Compared to 27US11 or 27m152, Whereas Depletion
of CD8 T Cells Does
BALB/c mice were either (A) untreated; or (B) and (C) treated 3 and 2
days before the time of infection with 200 lg a-CD4 MAb (GK1.5) or
a-CD8 MAb (53–6.7), respectively. Mice were infected with 2.5 3 10
5
pfu of 27 gfp, 27US11, or 27m152 on day 0, and footpads and spinal
cord were harvested on day 6. This experiment was distinct from the
experiments shown in Figures 6 and 7, but the ﬁndings for A and C
are similar to those shown in Figures 6A and 7C, respectively.
Found at DOI: 10.1371/journal.ppat.0010007.sg001 (357 KB EPS).
Accession Numbers
The Swiss-Prot (http://www.ebi.ac.uk/swissprot) accession number for
the MCMV m152 gene product is Q69G18, and for the HCMV US11
gene product is P09727. The Swiss-Prot accession number for vhs is
Q69G18, and for the US12 gene product ICP47 is P03170. Swiss-Prot
accession numbers for UL26, UL26.5, and UL27 are P10210 and
P10211.
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